$OTCMKTS:XSNX Archives

NovAccess Global (OTCMKTS:XSNX) Stock Rockets On Filing of Orphan Drug Application for TLR-AD1

July 20, 2022July 20, 2022 Ash K $NovAccess Global (OTCMKTS:XSNX), $OTCMKTS:XSNX, $XSNX, $XSNX news, $XSNX stock

Biomedical firm, NovAccess Global (OTCMKTS:XSNX), develops novel immunotherapies for brain tumor patients. The ultimate goal is to discover, develop and